Poseida Therapeutics to Present New Clinical Data From Phase 1 Study of Allogeneic CAR-T P-BCMA-ALLO1 in Patients With Relapsed/Refractory Multiple Myeloma at 21ST International Myeloma Society Annual Meeting
poseida therapeutics將在第21屆國際骨髓瘤學會年會上發佈關於Allogeneic CAR-t P-BCMA-ALLO1相位1研究在復發/難治性多發性骨髓瘤患者中的新臨床數據